Galera announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 roman trial of avasopasem

Corrected topline phase 3 roman data demonstrate primary endpoint achieved statistical significance in reducing the incidence of radiotherapy-induced severe oral mucositis (p=0.045)
GRTX Ratings Summary
GRTX Quant Ranking